MALDI Plates for Mass SpectrometryClinical validation

In collaboration with the company Affipro, we have initiated the development of a 3-D printed single-use device called sample target plate. They are currently used for the method called Microbe MALDI Biotyping, which is applied in clinical microbiology for the identification of pathogens without the need for time-consuming microbial growth in expensive selective media. Using nanotechnologies developed at IQS nano, we have already prepared new prototypes of these target plates, which exhibit good performance for MALDI Biotyping. They may represent a cost-effective and versatile alternative compared to the currently available equipment produced by traditional technologies.

Pipeline

Product / technology
(target/biomarker)
Discovery stageDevelopmentScale-upCommercializationCommercial partner
Proof-of-conceptPre-clinic dataClinical validationCE / IVDRMarket
MALDI
Plates
Progress: 42 %IQS Group, Affipro

Contact

GeneSpector s.r.o.
Petrska 1180/3 110 00 Prague, Czech Republic
ID No / IČO: 09404546, file number C 335854
administered by the Municipal Court in Prague

General queries,
investors & partners

info@genespector.com

 

US subsidiary

GeneSpector Innovations USA, Inc.
3500 South Dupont Highway
Dover DE 19901

EU subsidiary

GeneSpector s.r.o.
Petrska 1180/3
110 00 Prague, Czech Republic
ID No / IČO: 09404546
File number C 335854
administered by
the Municipal Court in Prague